SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
Titel:
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
Auteur:
Ronde, Jorma J. de Lips, Esther H. Mulder, Lennart Vincent, Andrew D. Wesseling, Jelle Nieuwland, Marja Kerkhoven, Ron Vrancken Peeters, Marie-Jeanne T. F. D. Sonke, Gabe S. Rodenhuis, Sjoerd Wessels, Lodewyk F. A.